Fingerprint
Dive into the research topics where Anne Wajja is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
Pelzer, P. T., Stuck, L., Martinez, L., Richards, A. S., Acuña-Villaorduña, C., Aronson, N. E., Bonnet, M., Carvalho, A. C., Chan, P.-C., Huang, L.-M., Fang, C.-T., Churchyard, G., Corral-Londoño, H. D., Datta, M., Espinal, M. A., Fielding, K., Fiore-Gartland, A. J., Garcia-Basteiro, A., Hanekom, W. & Hatherill, M. & 22 others, , 19 Dec 2024, (E-pub ahead of print) In: The Lancet Microbe. 100961.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile30 Downloads (Pure) -
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
Wajja, A., Nassanga, B., Natukunda, A., Serubanja, J., Tumusiime, J., Akurut, H., Oduru, G., Nassuuna, J., Kabagenyi, J., Morrison, H., Scott, H., Powell Doherty, R., Marshall, J. L., Cabrera Puig, I., Cose, S., Kaleebu, P. & TB042 Study Team, 1 Feb 2024, In: The Lancet Infectious Diseases. 24, 2, p. e78-e79Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile14 Downloads (Pure) -
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
Wajja, A., Nassanga, B., Natukunda, A., Serubanja, J., Tumusiime, J., Akurut, H., Oduru, G., Nassuuna, J., Kabagenyi, J., Morrison, H., Scott, H., Doherty, R. P., Marshall, J. L., Puig, I. C., Cose, S., Kaleebu, P., Webb, E. L., Satti, I., McShane, H. & Elliott, A. M. & 1 others, , 1 Mar 2024, In: The Lancet Infectious Diseases. 24, 3, p. 285-296 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile14 Downloads (Pure) -
Schistosome and malaria exposure and urban–rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials
POPVAC trial team, 1 Nov 2024, In: The Lancet Global Health. 12, 11, p. e1860-e1870Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile28 Downloads (Pure) -
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
POPVAC trial team, 1 Nov 2024, In: The Lancet Global Health. 12, 11, p. e1849-e1859Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile17 Downloads (Pure)